COLLABORATION DEVELOPS NEW GENERATION OF MICROBICIDAL AGENT

[Guest guest]

COLLABORATION DEVELOPS NEW GENERATION OF MICROBICIDAL

AGENT

Quick-Med Technologies, Inc., (QMDT) in collaboration

with the University of Florida at Gainesville (UF),

has developed a new generation of the company's Nimbus

technology making it significantly more cost-effective

and valuable in medical applications.

Nimbus is a powerful microbicidal agent that can be

permanently bonded to materials such as cotton, cotton

blends or polyurethane to create advanced wound

dressings, fabrics or other medical or consumer

products. The new technology significantly reduces

production cost and is highly effective against key

strains of bacteria that have become resistant to

antibiotics commonly used to treat infections.

Importantly, the new technology has been designed to

sharply reduce the possibility that any bacteria could

develop resistance to the treated articles.

The results are based on 6 years of research conducted

by QMT and UF on new techniques of bonding the

company's Nimbus technology to various substrates.

Prior test results have shown that this material can

kill up to 99.9999% of most bacteria types including

those often found on a person's skin, such as

Staphylococcus aureus, or Staph, as well as common

odor-causing bacteria and the fungus that causes

athlete's foot.

Nimbus is comprised of strands of a vast number of

microbicidal groups that are permanently bonded to a

variety of substrates, including wound dressing,

fibers, paper, apparel, and even hospital bedding and

gowns. This permanent bond is part of why germs do not

develop resistance. Other dressings use a process that

allows molecules to diffuse into the wound, which can

slow healing and increase the chance that bacteria

will develop resistance.

Quick-Med Technologies is a life sciences company

focused on developing proprietary, broad-based

technologies for consumer, industrial, and healthcare

use, as well as for advanced military and civilian

medical applications.

You are receiving NewsRx Medical Devices Alert per

your request entered at our website, www.NewsRx.com.

Please feel free to share this email with interested

colleagues, but do not forward unless requested. If

you are receiving this email in error, you may

unsubscribe from all alerts.

NewsRx does not and will not share your email address

with anyone. It is used solely for the purposes of

delivering to you requested free Alerts. Privacy

Policy and User Agreement

Copyright © 2005 NewsRx Inc. .

Designated trademarks and brands are the property of

their respective owners. NewsRx is headquartered at

2900 Paces Ferry Rd, Bldg D, Floor 2, Atlanta, GA,

30339. Phone: 770-507-7777 or 800-726-4550; Fax:

770-435-6800; Email: CustomerService@....